Navigation Links
Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report
Date:2/6/2008

BOSTON, Feb. 6 /PRNewswire/ -- CenterWatch, a publishing and information services company focused on market research about clinical trials, finds in a new report that the Asia-Pacific region is grabbing an increasing share of the global clinical trial market, and with new regulatory changes across the region, has already been growing at more than 50% in recent years.

According to the new 160-plus page report from CenterWatch entitled, Asia- Pacific's Growing Role in Global Clinical Trials, Asia Pacific countries are tapping into their power as a bloc to boost their role in the expanding global clinical trials market.

An important part of the report contains the results from CenterWatch's first-ever survey of clinical researchers in the region. CenterWatch surveyed more than 156 investigative sites from more than a dozen countries in Asia Pacific. The survey revealed, among other results, the key role of electronic data capture (EDC) of clinical trial information in this region.
Highlights of this report include:

* Charts of survey results from CenterWatch's ground-breaking investigator

survey of the region. Fifty charts with proprietary data are included.

* A pipeline of drugs in development in Asia-Pacific countries.

* Extensive interviews with executives from global pharmaceutical

companies and contract research organizations (CRO) who have on-the-

ground experience in the Asia-Pacific region.

* A breakdown of contract research organizations country-by-country.

The global CRO market has been a great worldwide growth story and the Asia-Pacific region has been one of the hottest areas for this growth. 2007 saw more CRO mergers and acquisitions--35--than in any previous year since CenterWatch began tracking the market in the mid 1990s when contract research took off.

"More than half of those acquisitions were made to take advantage of the growth in global clinical trials. The largest CROs are strengthening their worldwide infrastructures. Some smaller and mid-sized CROs are looking to become global players to attain the size needed to be considered by big pharmaceutical companies for their large, global trials. Asia-Pacific was a hotbed of activity for clinical trials," said Steve Zisson, editorial director of CenterWatch.

Sara Gambrill, senior editor at CenterWatch and author of the report, noted, "Asia-Pacific is becoming an integral player in global drug development, and will be taking a leadership position on more global clinical trials projects."

To purchase your copy of Asia-Pacific's Growing Role in Global Clinical Trials at the introductory rate of $795 (+ s/h), call us at 800-765-9647 or visit our online bookstore at http://www.centerwatch.com. This report is available in hardcopy or as a non-printable PDF.

Multi-reader discounts and corporate licenses are available. For more information, contact us at sales@centerwatch.com or 866-219-3440,ext. 4.

About CenterWatch

Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for professionals and patients. A Boston-based publishing and information services company focusing on the clinical research industry, CenterWatch is a business of Jobson Medical Information. CenterWatch provides proprietary data and information about clinical trials through a variety of publications, databases and information services used by pharmaceutical and biotech companies, CROs, SMOs and investigative sites involved in all aspects of clinical trials.

As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish information about active clinical trials that could be accessed by patients and their advocates. Today, CenterWatch has one of the largest databases of clinical trials actively recruiting patients on the Internet. For more information about CenterWatch's publications and services, please visit http://www.centerwatch.com.

Media Contact:

Steve Zisson

Editorial Director

CenterWatch

stephen.zisson@centerwatch.com

617-856-5950


'/>"/>
SOURCE CenterWatch
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body
2. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
3. Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
4. Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia
5. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
6. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
7. Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria
8. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
9. BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
10. CLIA Waiver Submitted for Rapid HIV Test Employs StatSures Barrel Technology
11. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/22/2017)... AVACEN Medical (AVACEN) announced that its CE-Marked ... those with the widespread pain associated with fibromyalgia in ... Essex, England commented, "I had ... no sleep at all, tremendous pain, with every movement ... [the AVACEN 100] enough, how this has and is ...
(Date:9/19/2017)... LOUISVILLE, Ky. , Sept. 19, 2017   ZirMed ... and predictive analytics, today announced that it has been ranked ... the Black Book™ Rankings 2017 User Survey. ZirMed ... software solution for large hospitals and medical centers over 200 ... in Black Book,s healthcare technology user survey history. ...
Breaking Medicine Technology:
(Date:10/13/2017)... LEXINGTON, Ky. (PRWEB) , ... October 13, 2017 , ... ... MD, MPH to become its next President and Chief Executive Officer, succeeding Dr. James ... and CEO Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Lori R. ... a member of ElderCounsel, a national organization of elder law and special needs planning ... laws and rules. It also provides a forum to network with elder law attorneys ...
(Date:10/13/2017)... ... , ... Ellevate Network, the leading network for professional women, brought together some ... at their inaugural Summit in New York City in June. The event was livestreamed ... over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
Breaking Medicine News(10 mins):